Four of them were males and three were females, and the median age was 58 years (range 24–70 years), which was not significantly different (p = 0.338) from the 48 MPN cases without CCN2 overexpression (median age 62 years, range 23–77 years). Here, CCN2 is linked to myeloproliferative disorder.